#USA #Homewood #skin rejuvenation #Rohrer Aesthetics #PIX:E

The Future of Aesthetics: PIX:E Clinical Study Results

In a groundbreaking development for the world of regenerative aesthetics, Rohrer Aesthetics has unveiled a new clinical study concerning their innovative treatment, PIX:E. As a prominent player in energy-based aesthetic technology, Rohrer Aesthetics continues to push the boundaries of what is possible in skin rejuvenation. Published in NewBeauty, this study explores PIX:E's promising capabilities, positioning it as a frontrunner in the evolution of preventative aesthetics.

The clinical trial, overseen by board-certified plastic surgeon Dr. Alan Durkin, has yielded remarkable feedback, showing a vast potential to both rejuvenate skin and stave off the visible signs of aging. The unique approach of PIX:E amalgamates various collagen-induction techniques within a single treatment protocol. Specifically, it integrates the FDA-cleared 4MHz radiofrequency microneedling system with both fractional and full-field ErYAG laser resurfacing, creating a robust platform for comprehensive skin care.

In an analysis involving 20 participants, an impressive 91% reported noticeable improvements in their skin tone and texture. Moreover, the treatment exhibited universal tolerability for all skin types, accommodating even those with sensitive or deeper skin tones. Dr. Durkin highlighted that PIX:E's fusion of the two gold-standard techniques not only streamlines the treatment process for clinics but revolutionizes care for patients. This proactive strategy allows for a focus on fostering skin’s regenerative processes rather than solely responding to the visible effects of aging.

Traditional anti-aging treatments typically come into play only after signs start to manifest. In stark contrast, PIX:E aims to proactively prevent these indicators by boosting the natural production of Type I collagen, the fundamental support behind youthful skin. This forward-thinking approach ensures longevity in skin quality and lays a solid foundation for sustained aesthetics and health.

The dual-modality design of PIX:E is set to rectify a variety of skin concerns—ranging from sagging skin, uneven texture, enlarged pores, sun damage, to scars from acne and stretch marks. Through addressing both superficial and deeper skin layers in one swift protocol, PIX:E presents a high-efficacy solution that does away with the previous necessity for multiple sessions or devices.

Liz Smith, Rohrer Aesthetics' Chief Marketing Officer, stated that the development of PIX:E was aimed at transforming the approach to skin rejuvenation in medical practices. The implications for patients are profound, encouraging a shift towards truly preventative care, where individuals can tackle the aging process before any visible markers emerge. PIX:E enables patients to maintain the integrity of their skin with fewer treatments and quicker recovery times, embodying the essence of precision, performance, and prevention.

In an era where regenerative aesthetics has become increasingly significant, Rohrer Aesthetics is dedicated to providing practitioners with clinically validated technologies that prioritize patient safety and results. NJ Wazaney, CEO of Rohrer Aesthetics, reinforces this commitment, emphasizing the importance of advancing practical therapies that enhance both patient experiences and provider success in their practices.

With more than 5,000 devices placed throughout the U.S. since its inception in 2014, Rohrer Aesthetics stands at the forefront of the aesthetics industry, driven by their foundational ideals of exceptional technology, outstanding service, and perpetual clinical education. As they continue to expand their offerings—including the innovative PIX:E treatment—their track record underlines their commitment to adapt and meet the changing landscape of aesthetic needs.

To learn more about Rohrer Aesthetics and their pioneering work in regenerative aesthetics, visit www.rohreraesthetics.com.